AU market earnings: Arcadium faces soft demand as neuron pharmaceuticals reaps royalty rewards
Arcadium reports a revenue dip to $255 million due to soft lithium demand, while Neuron Pharmaceuticals enjoys a royalty boost, signaling mixed market conditions and strategic adaptations in the face of global economic challenges.
[AI generated]
This video was created on 7 August for IG audiences by ausbiz.
Arcadium and Neuron tackle market challenges head-on
In the recent financial updates, Arcadium Lithium reported second-quarter revenue of $255 million, noting weak market sentiment and steady long-term demand for lithium, influenced by decreased demand for spodumene in China. The company is emphasizing efficient, high-quality operations, projecting a full-year capital expenditure of between $550 million and $700 million.
Meanwhile, Neuron Pharmaceuticals reported a royalty income of $13 million from Acadia Pharmaceuticals, with anticipated total royalties for 2024 ranging between $55 million and $61 million.
This information has been prepared by IG, a trading name of IG Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients.
CFDs are a leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your initial deposit, so please ensure that you fully understand the risks involved.
Speculate on commodities
Trade commodity futures, as well as 27 commodity markets with no fixed expiries.
- Wide range of popular and niche metals, energies and softs
- Spreads from 0.3 pts on Spot Gold, 2 pts on Spot Silver and 2.8 pts on Oil
- View continuous charting, backdated for up to five years
Put learning into action
Try out what you’ve learned in this commodities strategy article risk-free in your demo account.
Ready to trade commodities?
Put the lessons in this article to use in a live account – upgrading is quick and simple.
- Deal on our wide range of major and niche commodities
- Protect your capital with risk management tools
- Enjoy some of the best spreads on the market – Spot Gold from 0.3 points
Inspired to trade?
Put what you’ve learned in this article into practice. Log in to your account now.
Live prices on most popular markets
- Forex
- Shares
- Indices
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.
